Adverse events of video capsule endoscopy over the past two decades: a systematic review and proportion meta-analysis

• Published in: BMC gastroenterology Vol. 20; no. 1; p. 364
• Main Authors: Wang, Yuan-Chen, Pan, Jun, Liu, Ya-Wei, Sun, Feng-Yuan, Qian, Yang-Yang, Jiang, Xi, Zou, Wen-Bin, Xia, Ji, Jiang, Bin, Ru, Nan, Zhu, Jia-Hui, Linghu, En-Qiang, Li, Zhao-Shen, Liao, Zhuan
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 02.11.2020; BioMed Central; BMC
• Subjects: Adverse events; Aged; Bias; Capsule Endoscopy - adverse effects; Clinical medicine; Colon; Complications and side effects; Endoscopy; Esophagus; Failure; Gastroenterology; Gastrointestinal endoscopy; Humans; Inflammatory Bowel Diseases; Intestinal obstruction; Intestine, Small; Meta-analysis; Patients; Predictors; Sensitivity analysis; Small intestine; Stomach; Systematic review; Systematic review and meta-analysis; Temporal-trend; Video capsule endoscopy; China; Adverse events; Video capsule endoscopy; Temporal-trend; Systematic review and meta-analysis; Predictors
• ISSN: 1471-230X; 1471-230X
• DOI: 10.1186/s12876-020-01491-w

A full spectrum of video capsule endoscopy (VCE) adverse events over the past two decades has not been evaluated. We aimed to determine pooled rates, predictors and temporal-trend of VCE adverse events over the past two decades. Systematic search of PubMed and EMBASE for English-language publications reporting VCE adverse events (January 1, 2000 to March 31, 2019). Data were extracted independently by two investigators. Pooled VCE adverse event rates were calculated using the random or fixed model as appropriate. Predictors and temporal-trend of each adverse event were performed by meta-regression analyses. In total, 402 studies were identified, including 108,079 VCE procedures. Rate of retention, swallow disorder, aspiration, technical failure, and procedural adverse events were 0.73% (95% confidence interval [CI] 0.59-0.89%), 0.75% (95% CI 0.43-1.13%), 0.00% (95% CI 0.00-0.00%), 0.94% (95% CI 0.65-1.28%), 0.67% (95% CI 0.32-1.10%), respectively; incomplete examination rate of esophagus, stomach, small bowel, and colon were 9.05%, 7.69%, 12.08%, 19.19%, respectively. Patency capsule reduced retention rate by 5.04%, whereas known inflammatory bowel disease increased retention rate by 4.29%. Elder was the risk and protective factor for small bowel incomplete examination (0.30%) and swallow disorder (- 0.72%), respectively. Rates of retention and small bowel incomplete examination significantly declined over time (P = .0006 and P < .0001).. VCE adverse event rates were generally low, and retention and small bowel incomplete examination rates declined over the past two decades. Patients with known inflammatory bowel disease or elder should be alerted to high risk of retention or small bowel incomplete examination (PROSPERO: CRD42019139595).